Loading people...
Nandita Shangari is a Managing Director at RA Capital and a Board Director at GentiBio, focusing on life sciences and biotechnology investments. Prior to joining RA Capital, she served as a Managing Director at the Novartis Venture Fund, where she directed venture capital toward emerging pharmaceutical enterprises. During her broader tenure at Novartis, Shangari held roles in Business Development and Licensing and was a key contributor on the Kymriah Global Program Team, facilitating the commercial market launch of the cell therapy. She also held strategic and group head positions within Novartis Preclinical Investigative Toxicology after earning a BSc in Biochemistry and a PhD in Pharmaceutical Sciences from the University of Toronto. Her current professional focus centers on advancing clinical-stage therapeutics and supporting early-stage cell therapy platforms across the broader global biotechnology and pharmaceutical sectors.
